Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3

J Clin Endocrinol Metab. 2011 Feb;96(2):412-21. doi: 10.1210/jc.2010-1450. Epub 2010 Nov 17.

Abstract

Context: Uterine leiomyomas occur in 30-70% of reproductive-age women. Leiomyoma reduce implantation, increase miscarriage risk, and increase menstrual bleeding. We hypothesized that endometrial defects induced by leiomyoma result in menorrhagia and reproductive dysfunction.

Objectives: We evaluated the effect of leiomyoma on endometrial gene expression essential for implantation and hemostasis both in vivo and in primary endometrial stromal cells (ESC).

Design and setting: We conducted a case control and in vitro study at a university medical center.

Patients: The study included 24 subjects with or without leiomyoma. INTERVENTION/MAIN OUTCOME MEASURED: Endometrium, myometrium, leiomyoma, and ESC were obtained. Immunohistochemistry was used to evaluate TGF-β3, bone morphogenetic protein (BMP) receptors (BMPRs), plasminogen activator inhibitor 1 (PAI-1), and thrombomodulin in vivo. BMP-2 secretion was assessed by ELISA. ESC were treated with recombinant human (rh) BMP-2 or rhTGF-β3. Expression of HOXA10, LIF, BMPRs, antithrombin III (ATIII), thrombomodulin, and PAI-1 was assessed by quantitative RT-PCR.

Results: ESC from controls secreted more BMP-2 than those from women with leiomyoma. HOXA10 and LIF expression increased after rhBMP-2 treatment of normal but not leiomyoma-associated ESC. In vivo leiomyoma-associated endometrium expressed lower levels of BMPR 1A, 1B, and 2 than controls. Leiomyoma expressed high levels of TGF-β3; TGF-β3 treatment of ESC reduced expression of BMPRs. Similarly, leiomyoma-associated endometrium expressed less PAI-1 and thrombomodulin in vivo. In ESC, TGF-β3 reduced expression of PAI-1, ATIII, and thrombomodulin.

Conclusions: Leiomyoma-secreted TGF-β3 induces BMP-2 resistance in endometrium by down-regulation of BMPR-2, likely causing defective endometrial decidualization. TGF-β3 also reduces expression of PAI-1, ATIII, and thrombomodulin in endometrium, likely contributing to menorrhagia. A single molecular signal targeting endometrium may mediate both leiomyoma-induced infertility and bleeding.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antithrombin III / physiology
  • Blood Coagulation / genetics*
  • Bone Morphogenetic Protein 2 / biosynthesis*
  • Bone Morphogenetic Protein 2 / physiology*
  • Cells, Cultured
  • DNA, Complementary / biosynthesis
  • DNA, Complementary / genetics
  • Decidua / physiology*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunohistochemistry
  • Infertility, Female / etiology
  • Infertility, Female / genetics
  • Infertility, Female / pathology
  • Leiomyoma / complications
  • Leiomyoma / genetics
  • Leiomyoma / pathology*
  • Menorrhagia / etiology
  • Menorrhagia / pathology
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / physiology
  • RNA / biosynthesis
  • RNA / genetics
  • RNA / isolation & purification
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stromal Cells / physiology
  • Thrombomodulin / physiology
  • Transforming Growth Factor beta3 / genetics
  • Transforming Growth Factor beta3 / physiology*
  • Uterine Neoplasms / complications
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / pathology*

Substances

  • Bone Morphogenetic Protein 2
  • DNA, Complementary
  • Plasminogen Activator Inhibitor 1
  • Thrombomodulin
  • Transforming Growth Factor beta3
  • RNA
  • Antithrombin III